Yun Shin
Analyst
UBS
Equibles does not estimate personal net worth.
About Yun Shin
Yun Shin is recorded as Analyst at UBS. Yun Shin has spoken on 1 earnings call across 1 company, most recently for Harmony Biosciences Holdings, Inc. on February 24, 2026. The companies whose calls Yun Shin spoke on are classified in the Healthcare sector.
Yun Shin on recent calls
“First, so it seems like the settlement for generic entry with the three additional antiphilers are now four months early, March 2030, if pediatric exclusivity is granted from the prior settlement agreement of July 2030.”
Affiliation history
-
UBS
Analyst
Transcript header (unverified)
Current